Randy Allred

A two‐stage phase II trial design utilizing both primary and secondary endpoints

Xun Lin, Randy Allred, Glen Andrews, 2008, Pharmaceutical statistics.

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.

Randy Allred, Hubert Serve, Wolfgang E Berdel, 2005, Blood.